logo

For the Inventor, By the Inventor

Tokyo, Japan

Sbi Biotech Co., Ltd.

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 21.4



Forward Citations = 14

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Koji Ishida (8 out of 28 patents)

silverMedal Minkwon Cho (7 out of 7 patents)

bronzeMedal Eiji Esashi (4 out of 5 patents)

4.  Tomohide Yamazaki (4 out of 4 patents)

5.  Mayuki Endo (4 out of 4 patents)

6.  Yumiko Kamogawa (4 out of 4 patents)

7.  Ayumi Kotaki (2 out of 2 patents)

8.  Takayuki Irie (2 out of 6 patents)

9.  Masaaki Sawa (2 out of 18 patents)

10.  Jing Zhao (2 out of 2 patents)

11.  Yasue Shibata (2 out of 2 patents)

12.  Liying Wang (2 out of 5 patents)

13.  Yongli Yu (2 out of 5 patents)

14.  Chika Tanaka (2 out of 6 patents)

15.  Naoko Arai (2 out of 2 patents)


14 patents:

1. 10806749 - TLR inhibitory oligonucleotides and their use (2020-10-20),
2. 10730955 - Polynucleotides encoding anti-human receptor-type protein tyrosine phosphatase sigma antibodies (2020-08-04),
3. 10336834 - Methods of using anti-phospholipase D4 antibodies (2019-07-02),
4. 10190122 - Inhibitory oligonucleotide and use thereof (2019-01-29),
5. 9944715 - Anti-phospholipase D4 antibody (2018-04-17),
6. 9803026 - Anti-human receptor-type protein tyrosine phosphatase sigma antibody (2017-10-31),
7. 9688992 - Inhibitory oligonucleotide and use thereof (2017-06-27),
8. 9475876 - Anti oncostatin M receptor beta antibody used for treating atopic dermatitis (2016-10-25),
9. 8742113 - Furanone derivative (2014-06-03),
10. 8529896 - Anti-BST2 antibody (2013-09-10),
11. 8470992 - Anti-ILT7 antibody (2013-06-25),
12. 8435530 - Methods for suppressing activity of activated interferon-producing cells (2013-05-07),
13. 8119812 - Thiazolidinone derivative (2012-02-21),
14. 8084585 - Anti-ILT7 antibody (2011-12-27),
Company Overview
Sbi Biotech Co., Ltd. is a Tokyo-based company specializing in biopharmaceutical development and biotechnology solutions. The organization focuses on innovative research in areas such as drug discovery, regenerative medicine, and advanced therapeutic technologies. With a commitment to enhancing healthcare through scientific advancements, Sbi Biotech collaborates with various stakeholders in the life sciences sector to bring cutting-edge therapies to market, contributing to the global fight against diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

14 Patents

#1,601 in Tokyo

#3,586 in Japan

#42,333 in the World

Tokyo, JP
Tokyo, Japan

Sbi Biotech Co., Ltd.

Forward Citations = 14

27 inventors:

goldMedal Koji Ishida (8 out of 28 patents)

silverMedal Minkwon Cho (7 out of 7 patents)

bronzeMedal Eiji Esashi (4 out of 5 patents)

4.  Tomohide Yamazaki (4 out of 4 patents)

5.  Mayuki Endo (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sbi Biotech Co., Ltd.. Retrieved from https://idiyas.com/company/sbi-biotech-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…